Table 5.

Prevalence of malignancy in patients with asthma and ACOS

	Asthma	ACOS
	(n=474)	(n=176)
Malignant diseases, n (%)	92 (19.4%)	57 (29.5%)
Lung and mediastinal malignancy, n (%)	25 (27.2%)	15 (26.3%)
Hepatobiliary cancer, n (%)	11 (12.0%)	5 (8.8%)
Gastrointestinal cancer, n (%)	16 (17.4%)	22 (38.6%)
Urological cancer, n (%)	13 (14.1%)	15 (26.3%)
Gynecological cancer, n (%)	12 (13.0%)	0 (0.0%)
Head and neck cancer, n (%)	7 (7.6%)	3 (5.3%)
Breast cancer, n (%)	12 (13.0%)	0 (0.0%)
Hematological malignancies, n (%)	3 (3.3%)	3 (5.3%)
Femoral liposarcoma, n (%)	0 (0.0%)	1 (1.8%)
Unknown primary cancer, n (%)	0 (0.0%)	1 (1.8%)

Note: Double cancers are included.

Abbreviations: ACOS, asthma–COPD overlap syndrome; COPD, chronic obstructive pulmonary disease.